Literature DB >> 12676902

A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper ATPase.

B-E Kim, K Smith, M J Petris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676902      PMCID: PMC1735426          DOI: 10.1136/jmg.40.4.290

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  15 in total

Review 1.  ATP7A-related copper transport diseases-emerging concepts and future trends.

Authors:  Stephen G Kaler
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

Review 2.  Molecular basis of neurodegeneration and neurodevelopmental defects in Menkes disease.

Authors:  Stephanie Zlatic; Heather Skye Comstra; Avanti Gokhale; Michael J Petris; Victor Faundez
Journal:  Neurobiol Dis       Date:  2015-01-10       Impact factor: 5.996

Review 3.  The Endolysosomal System and Proteostasis: From Development to Degeneration.

Authors:  Bettina Winckler; Victor Faundez; Sandra Maday; Qian Cai; Cláudia Guimas Almeida; Huaye Zhang
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

4.  Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites.

Authors:  Marianne Paulsen; Connie Lund; Zarqa Akram; Jakob R Winther; Nina Horn; Lisbeth Birk Møller
Journal:  Am J Hum Genet       Date:  2006-06-05       Impact factor: 11.025

5.  Safety of intracerebroventricular copper histidine in adult rats.

Authors:  Kristen E Lem; Lauren R Brinster; Olga Tjurmina; Martin Lizak; Simina Lal; Jose A Centeno; Po-Ching Liu; Sarah C Godwin; Stephen G Kaler
Journal:  Mol Genet Metab       Date:  2007-03-01       Impact factor: 4.797

Review 6.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

7.  Participation of ATP7A in macrophage mediated oxidation of LDL.

Authors:  Zhenyu Qin; Eddy S Konaniah; Bonnie Neltner; Raphael A Nemenoff; David Y Hui; Neal L Weintraub
Journal:  J Lipid Res       Date:  2009-11-23       Impact factor: 5.922

8.  Phenotypic diversity of Menkes disease in mottled mice is associated with defects in localisation and trafficking of the ATP7A protein.

Authors:  Byung-Eun Kim; Michael J Petris
Journal:  J Med Genet       Date:  2007-05-04       Impact factor: 6.318

9.  Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.

Authors:  Ja Hye Kim; Beom Hee Lee; Yoo-Mi Kim; Jin-Ho Choi; Gu-Hwan Kim; Chong Kun Cheon; Han-Wook Yoo
Journal:  Metab Brain Dis       Date:  2014-06-13       Impact factor: 3.584

10.  Clinical outcomes in Menkes disease patients with a copper-responsive ATP7A mutation, G727R.

Authors:  Jingrong Tang; Anthony Donsante; Vishal Desai; Nicholas Patronas; Stephen G Kaler
Journal:  Mol Genet Metab       Date:  2008-08-26       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.